AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Sonoma Pharmaceuticals, Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SQ8K88
1.11▼ 0.04 (-3.48%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.15
Day's Range
1.11 – 1.13
52-Week Range
0.85 – 4.10
Volume
40.3K
Avg Volume
42.5K
Share Statistics
Shares Outstanding
Employees
168
Exchange
XNAS
Listed
2007-01-25
Share count as of August 6, 2026

Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Sonoma Pharmaceuticals, Inc. Common Stock (SNOA)
What is Sonoma Pharmaceuticals, Inc. Common Stock's Market Cap?
Sonoma Pharmaceuticals, Inc. Common Stock's Market Cap is $5.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Enterprise Value?
Sonoma Pharmaceuticals, Inc. Common Stock's Enterprise Value is $117.2K, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Price / Sales?
Sonoma Pharmaceuticals, Inc. Common Stock's Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EV / Revenue?
Sonoma Pharmaceuticals, Inc. Common Stock's EV / Revenue is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EV / EBITDA?
Sonoma Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?
Sonoma Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $21.9M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?
Sonoma Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA?
Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA is -$1.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?
Sonoma Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA Margin?
Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -5.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SNOAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+59.6%+48.1%+22.0%+56.6%
Cost of Revenue
Gross profit
% of revenue40.2%39.2%37.9%37.8%
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Total operating expenses
% of revenue40.9%45.5%53.5%43.8%
Loss from operations
% of revenue-0.6%-6.3%-15.6%-6.0%
Other Income
Loss from operations before income taxes
Income tax benefit
Net loss
% of revenue-5.2%-10.4%-18.8%-9.5%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)